BRMS1 mRNA expression has been shown to be markedly reduced in melanoma, breast cancer, ovarian cancer and non-small cell lung cancer cell lines, while stable overexpression of BRMS1 in these cell lines significantly inhibited their metastatic potential [29–31]. The gene discussed is BRMS1; the disease is ovarian cancer.